Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-11-15
2005-11-15
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C435S069300, C536S023700
Reexamination Certificate
active
06964770
ABSTRACT:
Described is a plasmid prepared by recombinant techniques which is used to prepare a vaccine againstY. pestis.
REFERENCES:
patent: 3137629 (1964-06-01), Cocking et al.
patent: 4455142 (1984-06-01), Martins et al.
patent: 5213796 (1993-05-01), Garcea et al.
Motin et al May 1994 Abstracts of the General Meeting of the American Society for Microbiology, vol. 94, pp 155.
Straley et al 1986, Infect Immun; 51(2): 445-454.
Watson et al 1988 Infect Immun. May 1988; 56(5): 1358-1363.
Bergman et al et al 1991 Journal of Bacteriology, 173; 1607-1616.
Injection and Immunity, “Passive Immunity To Yersiniae Mediated By Anti-Recombinant V Antigen and Protein A-V Antigen Fusion Peptide”, V.L. Motin et al., Oct. 1994, vol. 62, No. 10, p. 4192-4201.
InVirulence and Immunogenicity Of Pasteurella Pestis,“The Effects of Loss of Different Virulence Determinants On the Virulence And . . . ”, T.W. Burrows and G.A. Bacon, 1958, p. 278-291.
Microbial Pathogenesis, “Transcription of the yop regulon from Y. enterocolitica requires trans acting pYV & Chromosomal genes”, G. Cornelis et al., 1987, 2:367-379.
Molecular Microbiology, “The Surface-Located YopN Protein Is Involved In Calcium Signal Transduction inYersinia Pseudotuberculosis”, 1991, 5(4), 977-986.
Science, vol. 249, Aug. 1990, “Protein Tyrosine Phosphatase Activity of an Essential Virulence Determinant in Yersinia”, K. Guan and J.E. Dixon, p. 553-556.
“The Pigmentation ofPasteurella PestisOn a Defined Medium Containing Haemin”, S. Jackson & T.W. Burrows, 1956, p. 570-576.
Brit. J. Exp. Path. 37:597-583, “The Virulence-Enhancing Effect Of Iron On Non-Pigmented Mutants Of Virulent Strains OfPasteurella Pestis”, S. Jackson and T.W. Burrows.
Infection and Immunity, Oct. 1990, vol. 58, No. 10, “YopM Inhibits Platelet Aggregation and Is Necessary for Virulence ofYersinia Pestisin Mice”, Ka Yin Leung et al., p. 3262-3271.
In Protein Measurement With Folin Reagent, “Protein Measurement With The Folin Phenol Reagent”, O.H. Lowry et al., 1931, p. 265-275.
Microbial Pathogenesis, 1987, “Modulation of the Low-Calcium Response inYersinia Pestisvia Plasmid-Plasmid Interaction”, A.K. Sample et al. 2:442-453.
Microbial Pathogenesis, “Expression Of the Low Calcium Response InYersinia Pestis”, R.J. Mehigh et al., 1989, 6: 203-217.
J. of Bacteriology, Mar. 1991, “Secretion of Hybrid Proteins by the yersinia Yop Export System”, p. 1677-1685.
In A.V. Naumov (ed.), Microbiology and biochemistry of particularly dangerous infections, Anti-Plague Institute “Microbe” Press, Saratov, Russia, p. 3-11.
J. of Bacteriology, Aug. 1991, vol. 173, No. 16, “Analysis of virC, an Operon Involved in the Secretion of Yop Proteins byYersinia enterocolitica”, p. 4994-5009.
Infection and Immunity, Sep. 1990, “Secretion of Yop Proteins by Yersiniae”, T. Michiels et al., p. 2840-2849.
Analytical Biochemistry 117, 307-310 (1981) Silver Stain for Proteins in Polyacrylamide Gels: A Modified Procedure with Enhanced Uniform Sensitivity, J.H. Morrissey.
Infection and Immunity, Apr. 1983, “Vwa+ Phenotype ofYersinia enterocolitica”, R.D. Perry and R.R. Brubaker, vol. 40, No. 1, p. 2840-2849.
Infection and Immunity, Nov. 1986, “A Low-Ca2+ Response Operon Encodes the V Antigen ofYersinia Pestis”, R.D. Perry et al., vol. 54, No. 2, p. 428-434.
Infection and Immunity, Aug. 1988, “Inhibition of Phagocytosis inYersinia Pseudotuberculosis:a Virulence Plasmid-Encoded Ability Involving the Yop2b Protein”, R. Rosqvist et al., p. 2139-2143.
Science, vol. 258, Nov. 1992, “A Surface Protease and the Invasive Charactger of Plague”, O.A. Sodeinde et al. p. 1004-1007.
Infection and Immunity, Apr. 1982, vol. 36, No. 1, “Localization inYersinia Pestisof Peptides Associated With Virulence”, S.C. Straley and R.R. Brubaker, p. 129-135.
Infections and Immunity, Apr. 1989, vol. 57, No. 4, “Differential Clearance and Host-Pathogen Interactions of YopE-and YopK-YopL-Yersinia Pestisin BALB/c Mice”, S.C. Straley et al., p. 1200-1210.
Applied Microbiology, Nov. 1969, vol. 18, No. 5, “Congo Red-Agar Plating Medium for Detecting Pigmentation inPasteurella Pestis”, M.J. Surgalla and E.D. Beesley, p. 834-837.
J. of Bacteriology, Sep. 1979, vol. 139, No. 3, “Consequences of Ca2+ Deficiency on Macromolecular Synthesis and Adenylate Energy Charge inYersinia Pestis”, R.J. Zahorchhak et al., p. 792-799.
Bergman, T., et al, “Analysis of the V antigen 1crGVH-yopBD operon ofYersinia Pseudotuberculosis:Evidence of a regulatory role of LcrH and LcrV”, J. Bacteriol. 173:1607-1616, 1991.
Bolin, I., and H. Wolf-Watz. “The plasmid-encoded Yop2b protein ofYersinia pseudotuberculosisis a virulence determinat regulated by calcium and temperature at transcriptional level”. Mol. Microbiol. 2:237-245, 1988.
Brubaker, R.R. “The V antigen of yersiniae—an overview”.Contrib. Microbiol. Immunol.,12: 127-133, 1991.
Brubaker, R.R. 1991. “Factors promoting acute and chronic diseases caused by yersiniae”. Clin. Microbial. Rev. 4:309-324.
Brubaker, R.R., A.K. Sample, D.-Z. Yu, R.J. Zahorchak, P.C. Hu, and J.M. Fowler. 1987. “Proteolysis of V antigen fromYersinia pestis”. Microb. Pathog. 2:49-62.
Burrows, T.W. 1956. “An antigen determining virulence inPasteurella pestis.” Nature (London) 177:426-427.
Burrows, T.W., et al. 1958. “The Basis of virulence inPasteurella pestis: an antigen determining virulence”. Brit. J. Exp. Pathol. 37-481-493.
Burrows, T.W., et al, 1960. “V and W antigens in strains of Pasteurella pseudo-tuberculosis”, Br. J. Exp. Pathol. 41:38-44.
Carter, P.B., et al. 1980. “Plague virulence antigens fromYersinia enterocolitica” Infect. Immun. 28:638-640.
Fetherston, J.D., et al. 1992. “Loss of the pigmentation phenotype inYersinia pestisis due to the spontaneous deletion of 102kb, etc.” Mol. Micribiol 6:2693-2704.
Charnetzky, W.T., et al. 1982. “RNA synthesis inYersinia pestisduring growth restriction in calcium deficient medium.” J. Bacteriol. 149:1089-1095.
Gandecha, A.R., et al. 1992. “Production and secretion of a bifunctional staph-lococcal protein A: antiphytochrome single-chain Fv fusion protein inEscherichia coli” Gene 122:361-365.
Grodberg, J., and J.J. Dunn 1988 “ompT encodes theEscherichia coliouter membrane protease that cleaves 17 RNA polymerase during purification”. J. Bacteriol. 170:1245-1253.
Hakansson, S., et al 1993 “YopB and YopD constitute a novel class of Yersinia Yop proteins.” Infect. Immun. 61:71-80.
Leung,K.Y., and S.C. Straley 1989. “The yopM gne ofYersinia pestisencodes an released protein having homology with the human platelet surface protein GPIb”, J. Bacteriol. 171:4623-4623.
Lawton, W.D., et al. 1963. “Biosynthesis and purification of V and W antigen inPasteurella pestis.” J. Immunol. 91:179-184.
Lucier, T.A., and R.R. Brubaker. 1992. “Determination of genome size, macrorestriction pattern polymorphism, and nonpigmentation-specific deletion inYersinia pestisby pulsed-filed gel electrophoresis.” J. Bacteriol. 174:2078-2086.
Lowenadler, B., et al 1987. “A gene fusion system for generating antibodies against short peptides.” Gene 58:87-97.
Mehigh, R.J. and R.R. Brubaker. 1993. “Major stable peptides ofYersinia pestissynthesized during the low-calcium response”. Infect. Immun. 61:13-22.
Michiels, T., and G. Cornelis. 1988. “Nucleotide sequence and transcription analysis of yop51 fromYersinia enterocoliticaW22703” Microb. Pathog. 5:449-459.
Motin, V.L., et al. 1991. “The difference in the1crV-sequences betweenY. pestisandY. pseudotuberculosis,etc.” Microb. Pathog. 12:165-175.
Mulder, B., et al.
Brubaker Robert R.
Motin Vladimir L.
Smirnov George B.
Baskar Padma
Michigan State University
Smith Lynette R. F.
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Recombinant plasmid and a method of controlling the effects... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant plasmid and a method of controlling the effects..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant plasmid and a method of controlling the effects... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3484819